Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

The evidence on selective serotonin reuptake inhibitors (SSRIs) for major depressive disorder is unclear.